SHARONDA RANSOM: Open Payments
NPI 1891332656 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 18 payments from 6 companies in 2025. Trend: 2023 $634 · 2024 $438 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $237 |
| Novo Nordisk Inc | 4 | $76 |
| PFIZER INC. | 3 | $68 |
| Dexcom, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
Products named: Kerendia, Dexcom G6 Transmitter, ELIQUIS, Wegovy, BREZTRI, JARDIANCE, PREVNAR 20, Ozempic.
Industry payments across TX — which companies pay providers there.
